{"filing":{"accession":"0001106578-26-000124","url":"/filing/0001106578-26-000124","form_type":"4","issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_name_source":null,"issuer_ticker":"UTHR","issuer_url":"/issuer/0001082554","period_of_report":"2026-08-19","filed_date":"2026-08-20","acceptance_dt":"2026-08-20T16:37:07+00:00","acceptance_label":"2026-08-20 16:37 UTC","ingested_at":"2026-08-21T05:23:33.898496+00:00","ingested_label":"2026-08-21 05:23 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000124-index.htm","day_url":"/filings/2026-08-20"},"owners":[{"owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","url":"/insider/0001106578","anchor":"owner-0001106578","role":"Director, Officer (Chairperson & CEO)","officer_title":"Chairperson & CEO","is_director":true,"is_officer":true,"is_ten_percent":false,"is_other":false,"filing_anchor":"/filing/0001106578-26-000124#owner-0001106578"}],"line_owners":[{"owner_name":"ROTHBLATT MARTINE A","role":"Director, Officer (Chairperson & CEO)"}],"transactions":[{"id":9299690,"accession":"0001106578-26-000124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001106578-26-000124","line_url":"/filing/0001106578-26-000124#line-1","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":240.0,"shares_display":"240","price_per_share":522.4866,"price_display":"522.49","price_state":"stated","total_value":125396.784,"total_display":"125,396.78","total_whole":"125,397","shares_owned_after":333703.0,"shares_owned_after_display":"333,703","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299691,"accession":"0001106578-26-000124","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001106578-26-000124","line_url":"/filing/0001106578-26-000124#line-2","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1264.0,"shares_display":"1,264","price_per_share":523.6459,"price_display":"523.65","price_state":"stated","total_value":661888.4176,"total_display":"661,888.42","total_whole":"661,888","shares_owned_after":332439.0,"shares_owned_after_display":"332,439","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299692,"accession":"0001106578-26-000124","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001106578-26-000124","line_url":"/filing/0001106578-26-000124#line-3","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":441.0,"shares_display":"441","price_per_share":524.5108,"price_display":"524.51","price_state":"stated","total_value":231309.2628,"total_display":"231,309.26","total_whole":"231,309","shares_owned_after":331998.0,"shares_owned_after_display":"331,998","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299693,"accession":"0001106578-26-000124","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001106578-26-000124","line_url":"/filing/0001106578-26-000124#line-4","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":895.0,"shares_display":"895","price_per_share":525.5962,"price_display":"525.60","price_state":"stated","total_value":470408.599,"total_display":"470,408.60","total_whole":"470,409","shares_owned_after":331103.0,"shares_owned_after_display":"331,103","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299694,"accession":"0001106578-26-000124","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001106578-26-000124","line_url":"/filing/0001106578-26-000124#line-5","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2105.0,"shares_display":"2,105","price_per_share":526.7632,"price_display":"526.76","price_state":"stated","total_value":1108836.536,"total_display":"1,108,836.54","total_whole":"1,108,837","shares_owned_after":328998.0,"shares_owned_after_display":"328,998","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299695,"accession":"0001106578-26-000124","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001106578-26-000124","line_url":"/filing/0001106578-26-000124#line-6","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2135.0,"shares_display":"2,135","price_per_share":527.5763,"price_display":"527.58","price_state":"stated","total_value":1126375.4005,"total_display":"1,126,375.40","total_whole":"1,126,375","shares_owned_after":326863.0,"shares_owned_after_display":"326,863","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299696,"accession":"0001106578-26-000124","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001106578-26-000124","line_url":"/filing/0001106578-26-000124#line-7","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":528.5872,"price_display":"528.59","price_state":"stated","total_value":634304.64,"total_display":"634,304.64","total_whole":"634,305","shares_owned_after":325663.0,"shares_owned_after_display":"325,663","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299697,"accession":"0001106578-26-000124","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001106578-26-000124","line_url":"/filing/0001106578-26-000124#line-8","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":659.0,"shares_display":"659","price_per_share":529.5583,"price_display":"529.56","price_state":"stated","total_value":348978.9197,"total_display":"348,978.92","total_whole":"348,979","shares_owned_after":325004.0,"shares_owned_after_display":"325,004","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299698,"accession":"0001106578-26-000124","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001106578-26-000124","line_url":"/filing/0001106578-26-000124#line-9","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":201.0,"shares_display":"201","price_per_share":531.006,"price_display":"531.01","price_state":"stated","total_value":106732.206,"total_display":"106,732.21","total_whole":"106,732","shares_owned_after":324803.0,"shares_owned_after_display":"324,803","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299699,"accession":"0001106578-26-000124","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001106578-26-000124","line_url":"/filing/0001106578-26-000124#line-10","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80.0,"shares_display":"80","price_per_share":531.6223,"price_display":"531.62","price_state":"stated","total_value":42529.784,"total_display":"42,529.78","total_whole":"42,530","shares_owned_after":324723.0,"shares_owned_after_display":"324,723","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299700,"accession":"0001106578-26-000124","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001106578-26-000124","line_url":"/filing/0001106578-26-000124#line-11","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":532.63,"price_display":"532.63","price_state":"stated","total_value":106526.0,"total_display":"106,526.00","total_whole":"106,526","shares_owned_after":324523.0,"shares_owned_after_display":"324,523","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299701,"accession":"0001106578-26-000124","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001106578-26-000124","line_url":"/filing/0001106578-26-000124#line-12","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80.0,"shares_display":"80","price_per_share":535.215,"price_display":"535.22","price_state":"stated","total_value":42817.2,"total_display":"42,817.20","total_whole":"42,817","shares_owned_after":324443.0,"shares_owned_after_display":"324,443","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null}],"n_transactions":12,"line_constants":{"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true},"provenance":{"source_pass":"Layline","parse_status":"parsed","schema_version":null,"retrieved_at":"2026-08-21T05:23:33.898496+00:00","retrieved_label":"2026-08-21 05:23 UTC","primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000124-index.htm","accepted_at":"2026-08-20T16:37:07+00:00","accepted_label":"2026-08-20 16:37 UTC"},"related":[],"related_rule":"Other filings held for the same issuer and the same period of report. This is a heuristic match, not an authoritative amendment link: the store holds no 4/A-to-original relation and the catalog does not invent one.","canonical_url":"https://ebomi.com/filing/0001106578-26-000124","retrieved_at":"2026-08-23T21:34:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}